ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance

About this update from Icu Medical, Inc.

[{"type":"image","alt":"ICU Medical, Inc.","displaySize":"","headline":null,"caption":"ICU Medical, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":228,"height":75,"url":"https://media.zenfs.com/en/globenewswire.com/f1b81ec991808b15ae2c7684bd67adbe"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8pbdtcsN1HVf1uo_ylmJkA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f1b81ec991808b15ae2c7684bd67adbe","width":228,"height":75}},"lazy":false},{"type":"text","content":"SAN CLEMENTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended December 31, 2025.","length":254,"tagName":"p"},{"type":"text","content":"Fourth Quarter 2025 Results","length":27,"tagName":"p"},{"type":"text","content":"Fourth quarter 2025 revenue was $540.7 million, as compared to $629.8 million in the same period in the prior year. GAAP gross profit for the fourth quarter of 2025 was $203.0 million, as compared to $227.3 million in the same period in the prior year. GAAP gross margin for the fourth quarter of 2025 was 38%, as compared to 36% in the same period in the prior year. GAAP net loss for the fourth quarter of 2025 was $(15.7) million, or $(0.64) per diluted share, as compared to GAAP net loss of $(23.8) million, or $(0.97) per diluted share, for the fourth quarter of 2024. Adjusted diluted earnings per share for the fourth quarter of 2025 was $1.91 as compared to $2.11 for the fourth quarter of 2024. Adjusted EBITDA was $98.2 million for the fourth quarter of 2025 as compared to $105.5 million for the fourth quarter of 2024.","length":831,"tagName":"p"},{"type":"text","content":"Adjusted EBITDA and adjusted diluted earnings per share are measures calculated and presented on the basis of methodologies other than in accordance with GAAP. Please refer to the Use of Non-GAAP Financial Information following the financial statements herein for further discussion and reconciliations of these measures to GAAP measures.","length":338,"tagName":"p"},{"type":"text","content":"Vivek Jain, ICU Medical’s Chief Executive Officer, said, “Fourth quarter results were generally in line with our expectations."","length":132,"tagName":"p"},{"type":"te...

More updates from Icu Medical, Inc.